Fed. Circ. Knocks Down $1.7B Humira Patent Verdict

Law360, New York (February 23, 2011, 6:24 PM EST) -- The Federal Circuit overturned a record $1.67 billion patent verdict Wednesday, negating a Texas jury's finding that Abbott Laboratories' arthritis drug Humira infringed a patent held by a Johnson & Johnson subsidiary.

The U.S. Court of Appeals for the Federal Circuit found that the key claims of Centocor Ortho Biotech Inc.'s patent were invalid for lack of written description.

The court concluded the jury in the U.S. District Court for the Eastern District of Texas lacked substantial evidence for its June 2009 verdict, the largest of...
To view the full article, register now.